Operating Lease, Right-of-Use Asset of Scinai Immunotherapeutics Ltd. from 31 Dec 2021 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Scinai Immunotherapeutics Ltd. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2021 to 30 Jun 2025.
  • Scinai Immunotherapeutics Ltd. Operating Lease, Right-of-Use Asset for the quarter ending 30 Jun 2025 was $1,837,000, a 81% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Scinai Immunotherapeutics Ltd. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $1,837,000 +$823,000 +81% 30 Jun 2025 6-K 02 Sep 2025 2025 Q2
Q4 2024 $1,868,000 +$668,000 +56% 31 Dec 2024 6-K 02 Sep 2025 2025 Q2
Q2 2024 $1,014,000 -$311,000 -23% 30 Jun 2024 6-K 09 Sep 2024 2024 Q2
Q4 2023 $1,200,000 -$252,000 -17% 31 Dec 2023 20-F 07 May 2025 2024 FY
Q2 2023 $1,325,000 30 Jun 2023 6-K/A 18 Aug 2023 2023 Q2
Q1 2023 $1,430,000 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 $1,452,000 -$355,000 -20% 31 Dec 2022 20-F 15 May 2024 2023 FY
Q4 2021 $1,807,000 31 Dec 2021 10-K 17 Apr 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.